Metabolic syndrome in bipolar disorders

Area of Science:

• Psychiatry
• Metabolic Disorders
• Epidemiology

Background:

• Metabolic syndrome (MetS) is a cluster of conditions that increase the risk of heart disease, stroke, and type 2 diabetes.
• Bipolar disorder is a mental health condition characterized by extreme mood swings.
• Comorbidities between mental health disorders and metabolic conditions are increasingly recognized.

Purpose of the Study:

• To review the existing literature on the prevalence of metabolic syndrome (MetS) in patients diagnosed with bipolar disorder.
• To identify and summarize the key risk factors associated with MetS in this patient group.

Main Methods:

• A comprehensive electronic literature search was conducted across major databases: PubMed, Google Scholar, and Science Direct.
• Studies published between 2004 and June 2011 reporting on MetS prevalence in bipolar disorder patients were included.
• Data from 34 identified articles, with sample sizes ranging from 15 to 822 patients, were analyzed.

Main Results:

• Prevalence rates of MetS in bipolar disorder patients varied significantly, ranging from 16.7% to 67% across the reviewed studies.
• No consistent sociodemographic risk factors for MetS were identified.
• Clinical risk factors included longer illness duration, bipolar I disorder, increased depressive and manic episodes, difficult-to-treat episodes, depression at onset, less healthy diet, lack of physical activity, and family history of diabetes.

Conclusions:

• Metabolic syndrome is notably prevalent among individuals with bipolar disorder.
• Clinical characteristics of bipolar disorder, rather than demographic factors, appear to be significant predictors of MetS.
• Further research and clinical attention are warranted to address the high burden of metabolic complications in bipolar disorder patients.